174 related articles for article (PubMed ID: 15889973)
1. Dyslipidemia and lipid-lowering therapy in the elderly.
Deedwania P; Volkova N
Expert Rev Cardiovasc Ther; 2005 May; 3(3):453-63. PubMed ID: 15889973
[TBL] [Abstract][Full Text] [Related]
2. Treatment of dyslipidemia in the elderly.
Shao H; Chen LQ; Xu J
J Geriatr Cardiol; 2011 Mar; 8(1):55-64. PubMed ID: 22783285
[TBL] [Abstract][Full Text] [Related]
3. Perspectives on dyslipidemia and coronary heart disease in women: an update.
Bittner V
Curr Opin Cardiol; 2006 Nov; 21(6):602-7. PubMed ID: 17053411
[TBL] [Abstract][Full Text] [Related]
4. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium.
Goff DC; Bertoni AG; Kramer H; Bonds D; Blumenthal RS; Tsai MY; Psaty BM
Circulation; 2006 Feb; 113(5):647-56. PubMed ID: 16461837
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus.
Jones PH
Am J Cardiol; 2007 Feb; 99(4A):133B-140B. PubMed ID: 17307065
[TBL] [Abstract][Full Text] [Related]
6. Management of dyslipidemia in diabetes.
Solano MP; Goldberg RB
Cardiol Rev; 2006; 14(3):125-35. PubMed ID: 16628021
[TBL] [Abstract][Full Text] [Related]
7. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
Fazio S
Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
[TBL] [Abstract][Full Text] [Related]
8. Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia.
Ali YS; Linton MF; Fazio S
Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):142-6. PubMed ID: 18316949
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis.
Petrella RJ; Merikle E; Jones J
Clin Ther; 2007 Apr; 29(4):742-50. PubMed ID: 17617298
[TBL] [Abstract][Full Text] [Related]
10. Managing dyslipidemia in chronic kidney disease.
Harper CR; Jacobson TA
J Am Coll Cardiol; 2008 Jun; 51(25):2375-84. PubMed ID: 18565393
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of dyslipidemia in clinical practice].
Paragh G; Harangi M
Orv Hetil; 2006 Mar; 147(9):389-94. PubMed ID: 16619956
[TBL] [Abstract][Full Text] [Related]
12. Low HDL-C: a secondary target of dyslipidemia therapy.
Rosenson RS
Am J Med; 2005 Oct; 118(10):1067-77. PubMed ID: 16194634
[TBL] [Abstract][Full Text] [Related]
13. Management of lipid abnormalities associated with end-stage renal disease.
Liu J; Kalantarinia K; Rosner MH
Semin Dial; 2006; 19(5):391-401. PubMed ID: 16970739
[TBL] [Abstract][Full Text] [Related]
14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
15. Is it necessary to add fibrate to statin therapy in the management of dyslipidemia of metabolic syndrome?
Turhan H; Yetkin E
Int J Cardiol; 2006 Jun; 110(2):276-7. PubMed ID: 16364471
[TBL] [Abstract][Full Text] [Related]
16. The dyslipidemia of chronic renal disease: effects of statin therapy.
Ozsoy RC; van Leuven SI; Kastelein JJ; Arisz L; Koopman MG
Curr Opin Lipidol; 2006 Dec; 17(6):659-66. PubMed ID: 17095911
[TBL] [Abstract][Full Text] [Related]
17. The use of lipid-lowering drug therapy in children and adolescents.
Avis HJ; Vissers MN; Wijburg FA; Kastelein JJ; Hutten BA
Curr Opin Investig Drugs; 2009 Mar; 10(3):224-31. PubMed ID: 19333879
[TBL] [Abstract][Full Text] [Related]
18. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial.
Grover SA; Lowensteyn I; Joseph L; Kaouache M; Marchand S; Coupal L; Boudreau G;
Arch Intern Med; 2007 Nov; 167(21):2296-303. PubMed ID: 18039987
[TBL] [Abstract][Full Text] [Related]
19. The treatment of dyslipidemia--what's left in the pipeline?
Rau O; Zettl H; Popescu L; Steinhilber D; Schubert-Zsilavecz M
ChemMedChem; 2008 Feb; 3(2):206-21. PubMed ID: 17963209
[TBL] [Abstract][Full Text] [Related]
20. Lipid management in the geriatric patient.
Nair AP; Darrow B
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):185-206. PubMed ID: 19217519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
